Format

Send to

Choose Destination
See comment in PubMed Commons below
Pediatr Blood Cancer. 2010 Dec 1;55(6):1227-30. doi: 10.1002/pbc.22752.

Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent pediatric patients.

Author information

1
Department of Pediatrics, Children's Hospital of Philadelphia, Pennsylvania, Philadelphia, USA.

Abstract

We report two cases of primary CNS lymphoma (PCNSL) treated with high-dose methotrexate. Though standard adult treatment of PCNSL incorporates whole-brain radiotherapy, the literature suggests it may be possible to delay or avoid radiotherapy and the associated increased risk of neurologic sequelae in pediatric patients. Studies in adults indicate methotrexate therapy can be effective against PCNSL and has advantages over the current standard of treatment. Both patients have no evidence of disease 9 and 7 years after treatment, suggesting high-dose methotrexate may lead to disease control in pediatric patients with PCNSL while avoiding the effects of radiotherapy.

PMID:
20882580
DOI:
10.1002/pbc.22752
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center